documents: FDA-2013-D-0575-0045

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2013-D-0575-0045 FDA FDA-2013-D-0575 Guidance for Industry; Expedited Programs for Serious Conditions – Drugs and Biologics - Final Guidance Other Guidance 2023-12-01T05:00:00Z 2023 12 2023-12-01T05:00:00Z   2026-01-03T12:40:21Z   1 0 09000064862bd2eb

Links from other tables